Skip Navigation


Brain Advance Access originally published online on July 10, 2006
Brain 2006 129(9):2436-2446; doi:10.1093/brain/awl172
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/9/2436    most recent
awl172v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vucic, S.
Right arrow Articles by Kiernan, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vucic, S.
Right arrow Articles by Kiernan, M. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease

Steve Vucic and Matthew C. Kiernan

Prince of Wales Medical Research Institute and Prince of Wales Clinical School, University of New South Wales and Institute of Neurological Sciences, Prince of Wales Hospital Randwick, Sydney, Australia

Correspondence to: Matthew C. Kiernan, Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia E-mail: M.kiernan{at}unsw.edu.au

The dying forward hypothesis of motor neuron disease (MND) suggests that corticomotoneurons induce excitotoxic anterior horn cell death, with involvement of the glutamatergic neurotransmitter system. The aim of the present study was to apply novel threshold tracking transcranial magnetic stimulation (TMS) techniques in conjunction with peripheral nerve excitability studies in MND patients to further investigate the dying forward hypothesis and possibly determine the site of disease onset. Studies were undertaken in 23 MND patients using a 90-mm circular coil connected to a BiStim magnetic stimulator for cortical studies and electrical stimulation for peripheral nerve excitability studies. Motor-evoked potentials and compound muscle action potentials (CMAPs) were recorded from the right abductor pollicis brevis in the same setting. Measures of cortical and peripheral nerve excitability were correlated with clinical and neurophysiological parameters of disease severity. Short-interval intracortical inhibition (SICI) was significantly reduced in MND patients compared with controls (MND group = 3.6 ± 0.8%; controls = 8.5 ± 1.0%, P < 0.001), most prominently in MND patients with limb-onset disease. Changes in intracortical inhibition were accompanied by alterations in the magnetic stimulus–response curve, cortical silent period duration and resting motor threshold, all indicative of cortical hyperexcitability. Although the reduction in SICI was more pronounced in MND patients with less severe disease, as assessed by the CMAP amplitude, it remained evident even in MND patients with advanced disease. Measures of peripheral disease burden, namely the CMAP amplitude (r = –0.6) and neurophysiological index (r = –0.6), correlated with cortical hyperexcitability changes, as did the strength-duration time constant (r = –0.6), a peripheral marker of axonal excitability. Simultaneous assessment of central and peripheral nerve excitability has established the presence of co-existent upper and lower motor neuron dysfunction, with cortical hyperexcitability an early feature in MND.

Key Words: cortical hyperexcitability; MND; threshold tracking

Abbreviations: AHC, anterior horn cell; ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Score—Revised; APB, abductor pollicis brevis; CMAP, compound muscle action potential; CMCT, central motor conduction time; CSP, cortical silent period; ISI, interstimulus interval; MEP, motor-evoked potential; MND, motor neuron disease; NI, neurophysiological index; RMT, resting motor threshold; SICI, short-interval intracortical inhibition; SR, stimulus–response; {tau}SD, strength–duration time constant; TMS, transcranial magnetic stimulation; UMN, upper motor neuron

Received February 15, 2006. Revised May 25, 2006. Accepted June 2, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
S. Vucic, G. A. Nicholson, and M. C. Kiernan
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Brain, June 1, 2008; 131(6): 1540 - 1550.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. J. Triggs and D. Cros
Case 40-2007 -- A 38-Year-Old Man with Weakness in the Hands
N. Engl. J. Med., December 27, 2007; 357(26): 2707 - 2715.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. Vucic, A. V Krishnan, and M. C Kiernan
Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1202 - 1208.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. Vucic and M. C Kiernan
Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 849 - 852.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.